EDTA/glycine-acid versus chloroquine diphosphate treatment for stripping Bg antigens from red blood cells Cover

.blurhash-client-img { display: none !important; }

EDTA/glycine-acid versus chloroquine diphosphate treatment for stripping Bg antigens from red blood cells

Immunohematology

Volume 15 (1999): Issue 2 (June 1999)

By: K. Champagne, P. Spruell, J. Chen, L. Voll and G. Schlanser

Paid access

|Oct 2020

Authors

K. Champagne

Consultation and Education, Gamma Biologicals, Subsidiary of Immucor, Houston, USA

P. Spruell

Gamma Biologicals, Subsidiary of Immucor, Houston, USA

J. Chen

Gamma Biologicals, Subsidiary of Immucor, Houston, USA

L. Voll

Gamma Biologicals, Subsidiary of Immucor, Houston, USA

G. Schlanser

Gamma Biologicals, Subsidiary of Immucor, Houston, USA

DOI: https://doi.org/10.21307/immunohematology-2019-615 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X

Journal RSS Feed

Language: English

Page range: 66 - 68

Published on: Oct 26, 2020

Published by: American National Red Cross

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

EDTA/glycine-acid (EGA) treatment chloroquine diphosphate (CDP) treatment,

indirect antiglobulin test (IAT)

Related subjects:

Clinical medicine,

Laboratory medicine

© 2020 K. Champagne, P. Spruell, J. Chen, L. Voll, G. Schlanser, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous article Volume 15 (1999): Issue 2 (June 1999)Next article